Dirk Schraven

Misha Luyer 

Professor, Catharina Hospital Eindhoven

Tim Knotnerus

CEO, Agomab Therapeutics

Jolanda Kluin

Professor, Erasmus MC

Eva van Rikxoort

CEO, Thirona

Bastiaan van der Baan

CEO, Lixte Biotechnology

Eline van Beest

CEO, Hybridize Therapeutics & Venture Partner, Thuja Capital

Jason LaRoche

Director Janssen Clinical Innovation, Johnson & Johnson

Hans Schikan

Top Team Member Life Sciences & Health, Health~Holland

Tol Trimborn

Venture Partner, bioqube ventures

Carine van den Brink

Partner, AXON Lawyers

Bruno Bruins

Chairman Alrijne Zorggroep & Former Minister of Health

Conny Bakker

Professor, TU Delft

Hugo Touw

Intensivist, Radboudumc

June Park

CEO, siRNAgen

Ellen Smit

Director, Rotterdam Square

Koenraad Wiedhaup

CEO, Leyden Labs

Ana Maiques

CEO, Neuroelectrics

Tamara Hoveling

PhD Researcher, TU Delft

Minmin Yen

CEO & Co-Founder, PhagePro

Willem van Weperen

CEO, Pluvia Biotech

Stan Wang

CEO & Founder, Thymmune Therapeutics

Noud Steffens

CCO, Haermonics

Barend Bouma

European Patent Attorney & Associate Partner, NLO

Ben Brigou

Paul Korte

Clemence Ross-van Dorp

Board Member, FAST

Dorien Zwart

Professor of General Practice/Family Medicine, UMC Utrecht

Martine Breteler

Medical Technologist, UMC Utrecht

Michel de Baar

Executive Director, BD&L - Infectious Diseases & Vaccines, CardioMetabolic- and Immunology Diseases, MSD

Chris Cardon

CEO, Ziphius

Josi Boeijen

GP Trainee & PhD Student, UMC Utrecht

Arnoud Huisman

CEO & Chairman of the Board, Oncode Accelerator

Marlene Végh

CEO, Catalyze

Jan De Kerpel

Managing Director, Head of Life Science & Healthcare, Van Lanschot Kempen

Karla van Rooijen

Director of Pharmaceutical Affairs & Medical Technology, Ministry of Health, Welfare and Sports

Willem de Vocht

Senior Manager Strategic Alliances, Johnson & Johnson

Sahar van Waalwijk van Doorn-Khosrovani

Pharmacist, CZ

Laura Duran

International Relations Manager, Health~Holland

Sanne Weijzen

VP Corporate Strategy and Head EU Operations, Neogene Therapeutics

Mike de Leeuw

CEO, MyLife Technologies

Elisabeth Vreede-Chabot

Patient Representative

Katrien Reynders-Frederix

Managing Director, Falcon Bio & Board Member, HollandBIO

Esther Peters

Benien Vingerhoed

Managing Director, FAST

Julien Patris

Head of Patient Advocacy and Public Policy, Corporate Communication, Digital Services, EMEA, argenx

Rob Williams

Chief Drug Development Scientist, Cancer Research UK

Fleur Pasman

Chief Operations Officer, Noory

Jarno Drost

Group Leader, Princess Máxima Center 

Jan Molenaar

Professor, Utrecht University Department of Pharmaceutical Sciences & Group Leader, Princess Máxima Center 

Marcelien Callenbach

PhD Candidate, Utrecht University

Jeanne LeClair

Vice President of Economic Development & Partnerships, Massachusetts Life Sciences Center

Ansa Wasim

Senior Manager | Global Innovation and Investment, Deloitte

Sarah Kolen

Cyber Strategy Consultant, Deloitte

Fiona Moreno

Cyber Strategy Consultant, Deloitte

Marco Fossatelli

Country Manager BeNeLux & International DEI Lead, Alnylam Pharmaceuticals

Frans Breuer

Frits Stulp

Industry Leader Life Sciences & Healtcare, Deloitte

Peter van der Spek

Professor - Department of Pathology & Clinical Bioinformatics, Erasmus MC

Mark Krul

 Mark Wijsman

Moderator